Emergent BioSolutions (EBS) Operating Income (2011 - 2026)
Emergent BioSolutions' Operating Income was -$125.1 million in Q2 2026, compared with $1.6 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Operating Income (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Emergent BioSolutions' Operating Income was -$66 million through Jun 30, 2026; for FY2025, it was $100.1 million.
- Operating Income shows a five-year compound annual growth rate of -25.6% (FY2020 to FY2025).
- In earlier years, Operating Income was -$108.7 million in FY2024, -$726.4 million in FY2023, -$170 million in FY2022 and $341.4 million in FY2021 (-22.1%).
- The Q2 2026 figure marks the lowest quarterly Operating Income since Q2 2024.
- Per Business Quant data, EBS's Operating Income in the three quarters before Q2 2026 was $10.5 million (Q1 2026), -$27.9 million (Q4 2025) and $76.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.21 Bn | 1,124.80 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 624.61 Bn | 543.14 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 510.48 Bn | 483.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 365.61 Bn | 319.99 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 296.78 Bn | 260.77 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.28 Bn | 234.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 234.72 Bn | 190.12 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.73 Bn | 167.93 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Emergent BioSolutions | 318.37 Mn | -432.53 Mn | 137.20 Mn | -125.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -125.10 Mn |
| Mar 31, 2026 | 10.50 Mn |
| Dec 31, 2025 | -27.90 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 49.90 Mn |
| Dec 31, 2024 | -9.50 Mn |
| Sep 30, 2024 | 64.50 Mn |
| Jun 30, 2024 | -203.50 Mn |
| Mar 31, 2024 | 39.80 Mn |
| Dec 31, 2023 | -43.80 Mn |
| Sep 30, 2023 | -242.10 Mn |
| Jun 30, 2023 | -292.90 Mn |
| Mar 31, 2023 | -147.60 Mn |
| Dec 31, 2022 | -55.30 Mn |
| Sep 30, 2022 | -45.30 Mn |
| Jun 30, 2022 | -76.30 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 286.80 Mn |
| Sep 30, 2021 | -44.70 Mn |
API Access
Emergent BioSolutions Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();